Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
PLRZ
PLRZ
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PLRZ News
Polyrizon Launches New Allergy Product NASARIX™
Feb 17 2026
PRnewswire
Polyrizon Launches New Allergy Product NASARIX™
Feb 17 2026
Newsfilter
Polyrizon Signs Agreement to Acquire Stake in Arrow Aviation
Feb 10 2026
stocktwits
Polyrizon to Acquire 51% Stake in Arrow Aviation
Feb 04 2026
NASDAQ.COM
Polyrizon Signs MOU to Acquire 51% Stake in Arrow Aviation
Feb 04 2026
seekingalpha
Polyrizon Signs MOU with Arrow Aviation for Strategic Acquisition
Feb 04 2026
Newsfilter
Polyrizon Ltd. Explores Strategic Investments in Aviation, AI, and Defense Sectors
Jan 13 2026
Globenewswire
Polyrizon (PLRZ) Reports Positive Preclinical Results for PL-14 Allergy Blocker
Jan 05 2026
NASDAQ.COM
Polyrizon Reports Positive Preclinical Results for PL-14 Allergy Blocker
Jan 05 2026
Globenewswire
GH Research PLC Shares Surge 18.1% on FDA IND Status Update Announcement
Jan 05 2026
Benzinga
Polyrizon Submits PL-16 FDA Application to Combat Flu
Jan 02 2026
Globenewswire
Polyrizon Launches PL-16 Nasal Spray to Combat Flu
Jan 02 2026
Newsfilter
Polyrizon Explores Investment Opportunities to Drive Revenue Growth
Dec 29 2025
Globenewswire
Polyrizon Submits FDA Pre-RFD for PL-16 Viral Blocker with Over 90% Efficacy
Dec 19 2025
Newsfilter
Polyrizon Unveils New Naloxone Hydrogel, Enhancing Drug Permeation
Dec 11 2025
Globenewswire
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker, Clinical Trials Set for 2026
Dec 08 2025
Newsfilter
Show More News
